Dyadic International, Inc.

DYAI XNAS • BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)

Historical Short Interest Share

American Express® Business Gold Card

Earn Up to 200K Membership Rewards® Points

4X on your top 2 spending categories. Transfer to 20+ airline & hotel partners. Terms apply.

Learn More

Market Cap

25M

Short interest (May 15)

0.2%

Net Short (Jun 03 ): 0.1%

Borrow Fee

0.64%

↑ 3.8%

Available Shares

500K

↑ 120.7%

Price Chart

Company Overview

Dyadic International Inc is a biotechnology platform company. It has developed a gene expression platform for producing commercial quantities of industrial enzymes and other proteins and has licensed this technology to third parties, such as Abengoa Bioenergy, BASF, Codexis and others, for use in industrial (non-pharmaceutical) applications. This technology is based on the Thermothelomyces heterothallica fungus, which the company named C1.

Company Info

Exchange: NASDAQ

Industry: BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)

CIK: 0001213809

Asset Type: CS

Market Data

Market Cap: $25,131,773

Employees: 5

Status: Active

Short Interest

Current Borrow Fee 0.64%

Range: 0.64% - 0.64%

Available Shares 500K

Range: 450K - 500K

Recent Changes

Fee Change: ↑ 11.1%

Available Change: ↓ 35.7%

Quick Actions

View Dilution Chart

Add to Watchlist Set Price Alert View Options Chain

Investment Risk

This is not financial advice. All investments carry risk. Do your own research before making investment decisions.

Weekly Research

Get Weekly Super Stonk Alerts

Never miss a squeeze opportunity. Get our weekly analysis of high short interest stocks, AI-discovered gems, and dilution warnings delivered to your inbox.

No spam • Unsubscribe anytime